Corporate news

14.11.2024
Ad-hoc: Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
12.11.2024
Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine
11.10.2024
Ad-hoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
08.10.2024
Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com